GlassScriptPhysician profile
Jeffrey P Leppert
NPI 1811027055
$895.72
in general payments reported to CMS, 2019-2025
10 companies · $24.63 in 2025
The $24.63 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.00 · 2022: $289 · 2023: $266 · 2024: $229 · 2025: $24.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $525.03 | 2022-2024 | Belbuca, Xtampza |
| Boston Scientific Corporation | $99.74 | 2022 | |
| Abbott Laboratories | $61.74 | 2022-2025 | Eterna, Proclaim |
| Grt US Holding, INC. | $48.49 | 2021-2022 | |
| Amgen INC. | $39.89 | 2021 | |
| Saluda Medical Americas, INC. | $38.91 | 2024 | Evoke |
| Nalu Medical, INC. | $30.73 | 2022 | |
| Abbvie INC. | $21.85 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.54 | 2022 | |
| Avanos Medical | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Leppert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.